Friday, September 18, 2020
Home Life Style Health & Fitness US to Eventually Make COVID-19 Vaccine Free for all

US to Eventually Make COVID-19 Vaccine Free for all

US Official say that COVID-19 vaccine will be free for all

By Steve Baragona

The Trump administration says it will make an eventual COVID-19 vaccine available for free to virtually anyone in the United States who wants it.

Insurance companies are expected to cover the vaccine for most Americans, according to a senior administration official at a briefing Tuesday to discuss the government’s efforts to develop a vaccine by the end of the year.

For those who are not insured, the official added, “Our role as the federal government is to ensure anyone who is vulnerable, cannot afford it and desires it gets it.”

Follow NewsGram on LinkedIn to know what’s happening around the world.

The official said Americans would get any vaccine produced with federal funding before it would be made available to other countries.

Share on Facebook Share on Twitter Share via Email Print this page COVID-19 Pandemic COVID-19 Vaccine to Be Free in US
A man stands outside an entrance to a Moderna, Inc., building in Cambridge, Mass., May 18, 2020. Moderna entered the first phase of a three-step clinical trial process for a COVID-19 vaccine in mid-March. VOA

“Our priorities are very clear. Let’s take care of Americans first,” the official said.

“To the extent there is surplus, we have an interest in ensuring folks around the world are vaccinated,” since the virus arrived through international travel, he noted.

Other countries are signing separate contracts to manufacture the vaccine elsewhere, he said.

“In no way are we inhibiting through our contracts those vaccines from getting to others around the world,” the official added.

As part of Operation Warp Speed, the administration is aiming to deliver 300 million doses of a vaccine by January 2021. Vaccines typically take a decade or more to develop.

Government contracts

The government has announced more than $3 billion in contracts to back companies in testing, manufacturing and distributing a vaccine. Congress has appropriated nearly $10 billion to develop vaccines, treatments and diagnostics for COVID-19.

The pandemic and lockdowns aimed at staunching the spread of the coronavirus that causes COVID-19 have devastated economies around the world. The Congressional Budget Office estimates that the U.S. economy will shrink by 11% in the second quarter of 2020 alone.

“While we’re investing billions of dollars in this effort, it’s to address a multitrillion-dollar challenge,” the official said, who could not be identified according to ground rules for the briefing.

Share on Facebook Share on Twitter Share via Email Print this page COVID-19 Pandemic COVID-19 Vaccine to Be Free in US
The AstraZeneca logo is shown on the company’s building in Shanghai, China. VOA

Fourteen vaccine candidates have been chosen from more than 100 in development. The government said it will select the most promising seven for clinical trials.

Also Read: WHO Sees ‘Green Shoots of Hope’ as Pandemic Continues

President Donald Trump’s administration has already announced support for candidates produced by three companies: Moderna, which entered the first phase of the three-step clinical trial process in mid-March; Johnson & Johnson, which plans to start phase 1 testing this summer; and AstraZeneca, which is entering the final, large-scale testing phase this summer with a vaccine developed by the University of Oxford. The administration says this vaccine could be available as soon as October if it works.

Federal funding is going toward building manufacturing capacity at the same time as vaccine candidates undergo testing, so that whatever vaccine proves safe and effective can be distributed as soon as possible.

The government has also signed contracts with companies that make the vials and syringes to package vaccines. (VOA)



Most Popular

Kids Who Take Steroids to Treat Asthma are at Increased Risk for Diabetes: Study

Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of developing diabetes, high blood pressure, and blood clots,...

Indians Should be Thankful to Their Genes for Low Mortality Rate: Scientists

A study conducted by top genetic experts has revealed that Indians should be thankful to their genes for tiding over the Covid pandemic with...

Hansal Mehta Feels the Need For More Films on LGBTQ Community

Filmmaker Hansal Mehta feels we need more films to be made on the LGBTQ community. "There has been an absolute change in our society as...

Smart Drug May Help in Treatment of Neurological Disorders

Scientists have created a smart drug delivery system that reduces inflammation in damaged nervous tissues and may help treat spinal cord injuries and other...

Efficacy of Yoga on Astronauts’ Health Needs to be Explored Further: ISRO Officials

India's human space flight programme will be a sustained activity and will not end just with Gaganyaan mission - the country's first human space...

Astronomers Find First Possible Intact Planet Orbiting White Dwarf Star

Using data from NASA missions, an international team of astronomers has found what may be the first intact planet orbiting a white dwarf, the...

Depression Needs to be Treated Like Any Other Illness: Gulshan Devaiah

Actor Gulshan Devaiah says the problem with accepting depression as a disease is that a lot of people consider it to be a state...

Pollution May Increase Stroke Risk in AFib Patients: Study

People with one of the most common heart disorders or atrial fibrillation (AFib) who are exposed to greater levels of pollution have a 1.2-fold...

Recent Comments

Donate to NewsGram to support quality journalism.